Research graph
References from Comprehensive identification of FoxO signaling as a promising prognostic and immunotherapeutic biomarker in glioma. Local targets link to admitted publications; unresolved targets remain external evidence.
Immunotherapy for glioma: current management and future application
10.1016/j.canlet.2020.02.002 · 2020 · External reference
Predictive value of procollagen c-protease enhancer protein on the prognosis of glioma patients
10.1016/j.heliyon.2024.e28089 · 2024 · External reference
Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance
10.1016/j.bbcan.2021.188616 · 2021 · External reference
Integrating new oral selective oestrogen receptor degraders in the breast cancer treatment
10.1097/cco.0000000000000892 · 2022 · External reference
FOXO signaling pathways as therapeutic targets in cancer
10.7150/ijbs.20052 · 2017 · External reference
FoxO integration of insulin signaling with glucose and lipid metabolism
10.1530/joe-17-0002 · 2017 · External reference
Resist or die: FOXO transcription factors determine the cellular response to chemotherapy
10.4161/cc.7.20.6920 · 2008 · External reference
Tumor suppressor genes and ROS: complex networks of interactions
10.1016/j.freeradbiomed.2011.09.035 · 2012 · External reference
FoxO1 is a regulator of MHC-II expression and anti-tumor effect of tumor-associated macrophages
10.1038/s41388-017-0048-4 · 2018 · External reference
FoxO1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor
10.1038/ni.1689 · 2009 · External reference
An essential role of the Forkhead-box transcription factor FoxO1 in control of T cell homeostasis and tolerance
10.1016/j.immuni.2009.02.003 · 2009 · External reference
T cells require FoxO1 to populate the peripheral lymphoid organs
10.1002/eji.200939427 · 2009 · External reference
The impact of the immune system on tumor: angiogenesis and vascular remodeling
10.3389/fonc.2014.00069 · 2014 · External reference
Advantages and possibility of transcription factors FOXOs in HCC
10.1002/cbf.70126 · 2025 · External reference
Recent advances in, and challenges of, anti-angiogenesis agents for tumor chemotherapy based on vascular normalization
10.1016/j.drudis.2021.07.024 · 2021 · External reference
The Immune Landscape of Cancer
10.1016/j.immuni.2018.03.023 · 2018 · External reference
TGFβ attenuates tumor response to PD-L1 blockade by contributing to exclusion of T cells
10.1038/nature25501 · 2018 · External reference
Tumor microenvironment characterization in gastric cancer identifies prognostic and immunotherapeutically relevant gene signatures
10.1158/2326-6066.cir-18-0436 · 2019 · External reference
Evolution of delayed resistance to immunotherapy in a melanoma responder
10.1038/s41591-021-01331-8 · 2021 · External reference
A novel necroptosis-associated lncRNA signature can impact the immune status and predict the outcome of breast cancer
2022 · External reference
Many forks in the path: cycling with FoxO
10.1038/onc.2008.23 · 2008 · External reference
The emerging roles of forkhead box (Fox) proteins in cancer
10.1038/nrc2223 · 2007 · External reference
Transcriptional cross talk between the forkhead transcription factor forkhead box O1A and the progesterone receptor coordinates cell cycle regulation and differentiation in human endometrial stromal cells
10.1210/me.2007-0058 · 2007 · External reference
Lipid metabolism and cancer immunotherapy: immunosuppressive myeloid cells at the crossroad
10.3390/ijms21165845 · 2020 · External reference
T cell exclusion, immune privilege, and the tumor microenvironment
10.1126/science.aaa6204 · 2015 · External reference
CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy
10.1038/s41467-021-20893-2 · 2021 · External reference
Combination of TMB and CNA stratifies prognostic and predictive responses to immunotherapy across metastatic cancer
10.1158/1078-0432.ccr-19-0558 · 2019 · External reference
Association of prior antibiotic treatment with survival and response to immune checkpoint inhibitor therapy in patients with cancer
10.1001/jamaoncol.2019.2785 · 2019 · External reference
